Skip to content

BrainInsight

by Hyperfine, Inc. 2 variants

510(k) K220815

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK220815 Date19 Jul 2022ClearedStatusActive

Official records

From the FDA record

Received by the FDA
21 Mar 2022
FDA decision
19 Jul 2022 (Substantially Equivalent)
FDA review time
120 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K220815 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QIH
Device class
Class II
Regulation
21 CFR Part 892.2050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

BrainInsight is a device classified under the Radiology advisory committee. It received a traditional 510(k) clearance as substantially equivalent to a predicate device.

The device was manufactured by Hyperfine, Inc. and cleared under K220815. It is authorized for distribution in the United States with FDA 510(k) clearance.

Similar devices

Other devices filed under FDA product code QIH (Automated Radiological Image Processing Software).

Other devices from Hyperfine, Inc.

See all devices from Hyperfine, Inc. →